![1]()
News
New diabetes drugs solidify their cardiovascular and renal benefits
January 7, 2019
CHICAGO – Empagliflozin’s heart failure and renal benefits surprised when reported in 2015. The evidence has grown stronger and broader since.
![1]()
News
Nasal glucagon ‘viable alternative’ to intramuscular administration
November 20, 2018
BERLIN – Severe hypoglycemia was reversed successfully in all patients with type 1 diabetes mellitus given nasal glucagon.
![1]()
Opinion
Transforming glycemic control at Norwalk Hospital
November 20, 2018
Norwalk Hospital created a Glycemic Care Team to focus on improving the quality of care for inpatients with diabetes.
![1]()
News
Lower glucose targets show improved mortality in cardiac patients
November 9, 2018
Lower blood glucose targets in critically ill cardiac patients are associated with lower 30-day mortality, compared with higher targets.
![1]()
News
Perioperative diabetes and HbA1c in mortality
October 4, 2018
Do preoperative hemoglobin A1c (HbA1c) and perioperative glucose predict outcomes in patients undergoing noncardiac and cardiac surgeries?
![1]()
News
Review protocols, follow reprocessing guidelines to cut device-related HAIs
September 11, 2018
Environmental pathogens associated with medical devices or device reprocessing are often the cause of HAI-related investigations.
![1]()
News
Plan now for outpatient diabetes tech in the hospital
September 4, 2018
ORLANDO – Getting ahead of the diabetes tech curve.
![1]()
News
Hospitalists target inpatient glycemic control
August 13, 2018
Hyperglycemia in hospitalized patients is an extraordinarily common and growing problem.
![1]()
News
Intranasal naloxone promising for type 1 hypoglycemia
July 17, 2018
ORLANDO – This development could help prevent autonomic failure in T1DM patients.
![1]()
News
Closed-loop insulin control for T2DM is feasible in hospital setting
July 12, 2018
ORLANDO – Noncritical patients tolerated automated devices and had fewer clinically significant hypoglycemic events.
